The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020.The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020.

The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development: Product portfolios of the top players in the tissue diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various tissue diagnostics products across geographies.

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Global Tissues Diagnostics Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.1.1 By Disease
5.1.2 By End User
5.1.3 By Product
5.1.4 By Technology
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidences of Cancer
5.2.1.2 Rapidly Increasing Aging Population
5.2.1.3 Growing Healthcare Expenditure
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements and Compliance
5.2.2.2 High Degree of Consolidation
5.2.2.3 Budget Constraints
5.2.3 Opportunities
5.2.3.1 High Growth in Emerging Markets
5.2.3.2 Increased Use of Personalized Medicine
5.2.4 Trends
5.2.4.1 Increasing Number of Reagent Rental Agreements

6 Tissue Diagnostics Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Antibodies
6.2.2 Kits
6.2.3 Reagents
6.2.4 Probes
6.3 Instruments
6.3.1 Slide-Staining Systems
6.3.2 Scanners
6.3.3 Tissue-Processing Systems
6.3.4 Other Instruments

7 Tissue Diagnostics Market, By Diseases
7.1 Introduction
7.2 Breast Cancer
7.3 Gastric Cancer
7.4 Lymphoma
7.5 Prostate Cancer
7.6 Non-Small Cell Lung Cancer
7.7 Other Diseases

8 Tissue Diagnostics Market, By Technology
8.1 Introduction
8.2 Immunohistochemistry (IHC)
8.3 in Situ Hybridization (ISH)
8.4 Digital Pathology and Workflow Management
8.5 Special Staining

9 Tissue Diagnostics Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Research Laboratories
9.4 Pharmaceutical Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Tissue Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Strategic Overview
11.3 Leading Players in the Tissue Diagnostics Market
11.4 Competitive Situation and Trends
11.4.1 New Products Launches and Product Upgrades
11.4.2 Acquisitions
11.4.3 Expansions
11.4.4 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships
11.4.5 Other Developments

12 Company Profiles
12.1 Introduction
12.2 Abbott Laboratories, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Agilent Technologies, Inc.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Bio Sb
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Biogenex Laboratories
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Cell Signaling Technology, Inc.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Danaher Corporation
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.7.4 MnM View
12.8 F. Hoffman-La Roche AG
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments
12.8.4 MnM View
12.9 Sakura Finetek Japan Co., Ltd.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments
12.10 Sigma-Aldrich Corporation
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Recent Development
12.10.4 MnM View
12.11 Thermo Fisher Scientific
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments
12.11.4 MnM View

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables

Table 1 Tissue Diagnostics Market Summary
Table 2 Rising Incidences of Cancer are the Primary Driver for the Market
Table 3 Stringent Regulatory Requirements is A Key Restraint for the Growth of the Market
Table 4 Emerging Economies Present Significant Growth Opportunities
Table 5 Increasing Number of Reagent Rental Agreements is A Major Trend for the Growth of This Market
Table 6 Market Size, By Product, 2013–2020 (USD Million)
Table 7 Market Size, By Consumable, 2013–2020 (USD Million)
Table 8 Market Size for Consumables, By Region, 2013–2020 (USD Million)
Table 9 Market Size for Antibodies, By Region, 2013–2020 (USD Million)
Table 10 Market Size for Kits, By Region, 2013–2020 (USD Million)
Table 11 Market Size for Reagents, By Region, 2013–2020 (USD Million)
Table 12 Market Size for Probes, By Region, 2013–2020 (USD Million)
Table 13 Market Size, By Instrument, 2013–2020 (USD Million)
Table 14 Market Size for Instruments, By Region, 2013–2020 (USD Million)
Table 15 Market Size for Slide-Staining Systems, By Region, 2013–2020 (USD Million)
Table 16 Market Size for Scanners, By Region, 2013–2020 (USD Million)
Table 17 Market Size for Tissue-Processing Systems, By Region, 2013–2020 (USD Million)
Table 18 Market Size for Other Instruments, By Region, 2013–2020 (USD Million)
Table 19 Market Size, By Disease, 2013–2020 (USD Million)
Table 20 Market Size for Breast Cancer, By Region, 2013–2020 (USD Million)
Table 21 Market Size for Gastric Cancer, By Region, 2013–2020 (USD Million)
Table 22 Market Size for Lymphoma, By Region, 2013-2020 (USD Million)
Table 23 Market Size for Prostate Cancer, By Region, 2013–2020 (USD Million)
Table 24 Market Size for Non-Small Cell Lung Cancer, By Region, 2013–2020 (USD Million)
Table 25 Market Size for Other Diseases, By Region, 2013–2020 (USD Million)
Table 26 Market Size, By Technology, 2013–2020 (USD Million)
Table 27 Market Size for Immunohistochemistry, By Region, 2013–2020 (USD Million)
Table 28 Market Size for in Situ Hybridization, By Region, 2013–2020 (USD Million)
Table 29 Market Size for Digital Pathology and Workflow Management, By Region, 2013-2020 (USD Million)
Table 30 Market Size for Special Staining, By Region, 2013–2020 (USD Million)
Table 31 Market Size, By End User, 2013–2020 (USD Million)
Table 32 Market Size for Hospitals, By Region, 2013–2020 (USD Million)
Table 33 Market Size for Research Laboratories, By Region, 2013–2020 (USD Million)
Table 34 Market Size for Pharmaceutical Companies, By Region, 2013-2020 (USD Million)
Table 35 Market Size for Contract Research Organizations, By Region, 2013–2020 (USD Million)
Table 36 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 37 Market Size, By Region, 2013–2020 (USD Million)
Table 38 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 39 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 40 North America: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 41 North America: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 42 North America: Market Size, By Disease, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 44 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 45 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 46 U.S.: Market Size, By Disease, 2013–2020 (USD Million)
Table 47 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 49 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 50 Canada: Market Size, By Disease, 2013–2020 (USD Million)
Table 51 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 52 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 53 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 54 Europe: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 55 Europe: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 56 Europe: Market Size, By Disease, 2013–2020 (USD Million)
Table 57 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 59 Asia: Market Size, By Product, 2013–2020 (USD Million)
Table 60 Asia: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 61 Asia: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 62 Asia: Market Size, By Disease, 2013–2020 (USD Million)
Table 63 Asia: Market Size, By Technology, 2013–2020 (USD Million)
Table 64 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 65 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 66 RoW: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 67 RoW: Tissue Diagnostics Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 68 RoW: Tissue Diagnostics Market Size, By Disease, 2013–2020 (USD Million)
Table 69 RoW: Tissue Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 70 RoW: Tissue Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 71 Market Developments Between 2012 and 2015
Table 72 New Product Launches and Product Upgrades, 2012–2015
Table 73 Acquisitions, 2012–2015
Table 74 Expansions, 2012–2015
Table 75 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships, 2012–2015
Table 76 Other Developments, 2012–2015

List of Figures

Figure 1 Global Tissue Diagnostics Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Tissue Diagnostics Market Size, By Product, 2015 vs. 2020 (USD Million)
Figure 8 Tissue Diagnostics Market Size, By Technology, 2015 vs. 2020 (USD Million)
Figure 9 Tissue Diagnostics Market Size, By Disease, 2015 vs. 2020 (USD Million)
Figure 10 Tissue Diagnostics Market Size, By End User, 2015 vs. 2020 (USD Million)
Figure 11 Tissue Diagnostics Market Size, By Region, 2015 vs. 2020 (USD Million)
Figure 12 Rising Incidences of Cancer to Drive Market Growth
Figure 13 Immunohistochemistry Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period (2015 to 2020)
Figure 15 Asia Holds Lucrative Growth Opportunities
Figure 16 Tissue Diagnostics Market Segmentation: By Disease
Figure 17 Tissue Diagnostics Market Segmentation: By End User
Figure 18 Tissue Diagnostics Market Segmentation: By Product
Figure 19 Tissue Diagnostics Market Segmentation: By Technology
Figure 20 Increasing Incidences of Cancer are Expected to Drive the Tissue Diagnostics Market During the Forecast Period
Figure 21 Increasing Healthcare Expenditure Will Drive the Tissue Diagnostics Market
Figure 22 Rapid Growth in Healthcare Expenditure in Emerging Markets is an Important Growth Opportunity
Figure 23 Tissue Diagnostics Market, By Product
Figure 24 Tissue Diagnostics Market Size, By Product, 2015 (USD Million)
Figure 25 Tissue Diagnostics Market Size, By Consumables, 2015 (USD Million)
Figure 26 North America to Command the Largest Share of the Consumables Product Segment in 2015
Figure 27 North America to Command the Largest Share of the Antibodies Product Segment in 2015
Figure 28 North America to Command the Largest Share of the Kits Product Segment in 2015
Figure 29 North America to Command the Largest Share of the Reagents Product Segment in 2015
Figure 30 North America to Command the Largest Share of the Probes Product Segment in 2015
Figure 31 Tissue Diagnostics Market Size, By Instrument, 2015 (USD Million)
Figure 32 North America to Command the Largest Share of the Instruments Product Segment in 2015
Figure 33 North America to Command the Largest Share of the Slide-Staining Systems Product Segment in 2015
Figure 34 North America to Command the Largest Share of the Scanners Product Segment in 2015
Figure 35 North America to Command the Largest Share of the Tissue-Processing Systems Product Segment in 2015
Figure 36 North America to Command the Largest Share of the Other Instruments Product Segment in 2015
Figure 37 Tissue Diagnostics Market, By Disease
Figure 38 Tissue Diagnostics Market Size, By Disease, 2015 (USD Million)
Figure 39 North America to Command the Largest Share of the Breast Cancer Disease Segment in 2015
Figure 40 Asia to Be the Fastest-Growing Segment in the Tissue Diagnostics Market for Gastric Cancer in 2015
Figure 41 Asia to Witness Highest Growth in the Lymphoma Disease Segment in 2015
Figure 42 North America to Command the Largest Share of the Prostate Cancer Disease Segment in 2015
Figure 43 North America to Command the Largest Share of the Non-Small Cell Lung Cancer Disease Segment in 2015
Figure 44 Asia to Be the Fastest-Growing Market in the Other Diseases Segment in 2015
Figure 45 Tissue Diagnostics Market Segmentation, By Technology
Figure 46 Tissue Diagnostics Market Size, By Technology, 2015 (USD Million)
Figure 47 North America to Dominate the Immunohistochemistry Technology Segment in 2015
Figure 48 Asia to Be the Fastest-Growing Market in the in Situ Hybridization  Technology Segment in 2015
Figure 49 Asia to Witness Highest Growth in the Digital Pathology and Workflow Management Technology Segment in 2015
Figure 50 North America to Dominate the Special Staining Technology Segment in 2015
Figure 51 Tissue Diagnostics Market Segmentation, By End User
Figure 52 Tissue Diagnostics Market Size, By End User, 2015 (USD Million)
Figure 53 North America to Dominate the Hospital End-User Segment in 2015
Figure 54 The  Research Laboratories End-User Segment in Asia to Witness the Highest Growth in the Forecast Period
Figure 55 Pharmaceutical Companies Segment in Asia to Witness Highest Growth in the Forecast Period
Figure 56 North America to Dominate the Contract Research Organizations End-User Segment in 2015
Figure 57 North America to Dominate the Other End-Users Segment in 2015
Figure 58 Tissue Diagnostics Market Segmentation, By Region
Figure 59 North America to Dominate the Global Tissue Diagnostics Market in the Forecast Period
Figure 60 Tissue Diagnostics Market in Asia to Witness the Highest Growth From 2015 to 2020
Figure 61 North America: Market Snapshot
Figure 62 U.S. is Expected to Be the Fastest-Growing Market in North America in 2015
Figure 63 Consumables to Command the Largest Share of the Tissue Diagnostics Market in North America During the Forecast Period
Figure 64 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 65 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 66 Breast Cancer to Form the Largest Disease Segment in North America in 2015
Figure 67 Immunohistochemistry to Form the Largest Technology Segment in North America in 2015
Figure 68 Hospitals to Form the Largest End-User Segment in North America in 2015
Figure 69 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Europe During the Forecast Period
Figure 70 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Europe During the Forecast Period
Figure 71 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Europe During the Forecast Period
Figure 72 Breast Cancer to Form the Largest Disease Segment in Europe in 2015
Figure 73 Immunohistochemistry to Form the Largest Technology Segment in Europe in 2015
Figure 74 Hospitals to Form the Largest End-User Segment in Europe in 2015
Figure 75 Asia: Market Snapshot
Figure 76 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Asia During the Forecast Period
Figure 77 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Asia During the Forecast Period
Figure 78 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Asia During the Forecast Period
Figure 79 Breast Cancer to Form the Largest Disease Segment in Asia in 2015
Figure 80 Immunohistochemistry to Form the Largest Technology Segment in Asia in 2015
Figure 81 Hospitals to Form the Largest End-User Segment in Asia in 2015
Figure 82 Consumables Command the Largest Share of the Tissue Diagnostics Market in RoW During the Forecast Period
Figure 83 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in RoW During the Forecast Period Between 2015–2020
Figure 84 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in RoW During the Forecast Period Between 2015–2020
Figure 85 Breast Cancer to Form the Largest Disease Segment in RoW in 2015
Figure 86 Immunohistochemistry to Form the Largest Technology Segment in RoW in 2015
Figure 87 Hospitals to Form the Largest End-User Segment in RoW in 2015
Figure 88 Key Developments in the Tissue Diagnostics Market, 2010-2015
Figure 89 Tissue Diagnostics Market Share Analysis, By Key Player, 2015
Figure 90 Snapshot of the Financial Performances of the Leading Market Players
Figure 91 Abbott Laboratories, Inc.: Company Snapshot
Figure 92 Agilent Technologies, Inc.: Company Snapshot
Figure 93 Danaher Corporation: Company Snapshot
Figure 94 F. Hoffman-La Roche AG: Company Snapshot
Figure 95 Sigma-Aldrich Corporation: Company Snapshot
Figure 96 Thermo Fisher Scientific: Company Snapshot